2005
DOI: 10.1007/s00398-005-0497-x
|View full text |Cite
|
Sign up to set email alerts
|

Inhalative Vasodilatatoren in der kardiochirurgischen Intensivmedizin

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
7
0
1

Year Published

2006
2006
2016
2016

Publication Types

Select...
3
1

Relationship

1
3

Authors

Journals

citations
Cited by 4 publications
(8 citation statements)
references
References 111 publications
0
7
0
1
Order By: Relevance
“…The ideal dosage will always be an bindividualQ dosage. In an actual review, Czeslick et al [21] recommend a dosage of 5 to 20 lg for an ultrasonic device.…”
Section: Discussionmentioning
confidence: 98%
“…The ideal dosage will always be an bindividualQ dosage. In an actual review, Czeslick et al [21] recommend a dosage of 5 to 20 lg for an ultrasonic device.…”
Section: Discussionmentioning
confidence: 98%
“…Inhalativen Vasodilatantien, wie zum Beispiel dem Iloprost oder dem Stickstoffmonoxid, sollte gegenüber intravenös zu applizierenden Substanzen der Vorzug gegeben werden. Die Inhalation führt zu einer pulmonal selektiveren Vasodilatation und dafür zu einer geringeren systemischen Wirkung auf den arteriellen Mitteldruck [19,20]. Die Autoren bevorzugen dazu die ultraschallgesteuerte Inhalation von aerosolisiertem Iloprost in moderater Dosierung (5 -10 µg…”
Section: Methodikunclassified
“…Due to its longer half-life of 20–30 minutes, the stable prostacyclin analog iloprost can be administered intermittently to ventilated and spontaneously breathing patients, and therefore offers significant advantages over short-acting inhaled vasodilators [ 34 ]. It is approved for the treatment of pulmonary arterial hypertension.…”
Section: Methodsmentioning
confidence: 99%